EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Date

Title

File

Times

2021-05-04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2021

1673

2021-04-30

NEXT DAY DISCLOSURE RETURN

1921

2021-04-20

VOLUNTARY ANNOUNCEMENT FURTHER UPDATE IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS RELATING TO THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

1903

2021-04-19

NEXT DAY DISCLOSURE RETURN

1913

2021-04-12

NEXT DAY DISCLOSURE RETURN

1920

2021-04-07

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2021

1664

2021-04-07

INSIDE INFORMATION APPROVAL TO COMMERCIALISE PRESERVATIVE-FREE UNIT-DOSE MOXIFLOXACIN HYDROCHLORIDE EYE DROPS IN THE PRC

1766

2021-03-26

NEXT DAY DISCLOSURE RETURN

1816

2021-03-25

NEXT DAY DISCLOSURE RETURN

1858

2021-03-25

NOTICE OF ANNUAL GENERAL MEETING

1862

2021-03-25

FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, 12 MAY 2021 (or any adjournment thereof)

1700

2021-03-25

PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING

1792

2021-03-24

NEXT DAY DISCLOSURE RETURN

1665

2021-03-23

NEXT DAY DISCLOSURE RETURN

1698

2021-03-19

VOLUNTARY ANNOUNCEMENT FURTHER UPDATE IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS RELATING TO THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

1640

2021-03-12

ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020

1873

2021-03-02

NOTICE OF BOARD MEETING

1630

2021-03-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2021

1650

2021-03-01

CHANGE OF ADDRESS OF PRINCIPAL SHARE REGISTRAR AND TRANSFER AGENT IN THE CAYMAN ISLANDS

1587

2021-02-24

INSIDE INFORMATION FURTHER UPDATES IN RELATION TO CO-DEVELOPMENT AGREEMENT - POSITIVE OUTCOME OF U.S. FDA SECOND PHASE 3 CLINICAL TRIAL IN DRY EYE DISEASE

1653

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT